Analystreport

Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target lowered by analysts at Morgan Stanley from $16.00 to $15.00. They now have an "equal weight" rating on the stock.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com